Icade SA
SWB:3IC
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
I
|
Icade SA
SWB:3IC
|
FR |
|
Nurix Therapeutics Inc
NASDAQ:NRIX
|
US |
|
Zhejiang China Commodities City Group Co Ltd
SSE:600415
|
CN |
|
E
|
E79 Gold Mines Ltd
ASX:E79
|
AU |
|
V
|
Vinci SA
XHAN:SQU
|
FR |
|
Bumi Resources Minerals Tbk PT
F:BUR
|
ID |
|
Bumi Resources Minerals Tbk PT
IDX:BRMS
|
ID |
|
E
|
Electromagnetic Geoservices ASA
F:E2M
|
NO |
|
L
|
Liontown Ltd
SWB:LIS
|
AU |
|
V
|
Vinci SA
F:SQU
|
FR |
|
X
|
Xaar PLC
OTC:XAARF
|
UK |
|
S
|
S&D Co Ltd
KOSDAQ:260970
|
KR |
Intrinsic Value
Is 3IC undervalued or overvalued?
See the intrinsic value estimate for 
Icade SA and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Icade Does
Icade SA is a French real estate company that owns, develops, and manages property. Its business is split between commercial real estate, such as offices and business parks, and property development, where it builds and sells homes and other buildings. It also has a major presence in healthcare real estate, owning specialized buildings like clinics and medical facilities.
- Headquarters
- France FR
- Employees
- 984
- IPO date
- Jan 7, 1985
Earnings Waterfall
Icade SA
The intrinsic value for Icade SA (3IC) under the Base Case is hidden EUR.
Compared with the current market price of 18.99 EUR, the stock appears hidden.
